Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy-Reference-Cited by-同舟云学术

Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy

Published:2016-04-01 Issue:4 Volume:2 Page:508
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Mougalian Sarah S.¹,Hernandez Mike²,Lei Xiudong²,Lynch Siobhan³,Kuerer Henry M.⁴,Symmans William F.⁵,Theriault Richard L.⁶,Fornage Bruno D.⁷,Hsu Limin⁶,Buchholz Thomas A.⁸,Sahin Aysegul A.⁵,Hunt Kelly K.⁴,Yang Wei Tse⁷,Hortobagyi Gabriel N.⁶,Valero Vicente⁶

Affiliation:

1. Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston

2. Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston

3. Center for Cancer and Blood Disorders, Arlington, Texas

4. Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston

5. Department of Pathology, University of Texas MD Anderson Cancer Center, Houston

6. Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston

7. Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston

8. Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting axillary response to neoadjuvant chemotherapy using peritumoral and intratumoral ultrasound radiomics in breast cancer subtypes;iScience;2024-09

2. Elevated Risk of Adverse Prognosis in Patients with T2-3 Stage Breast Cancer Exhibiting Non-Pathological Complete Response Following Neoadjuvant Chemotherapy: Significance of Regenerating Islet-Derived Family Member 4;Breast Cancer: Targets and Therapy;2024-09

3. Clipped Axillary Node as a Potential Surrogate for Overall Axillary Nodal Status in Inflammatory Breast Cancer Patients after Neoadjuvant Chemotherapy;Annals of Surgical Oncology;2024-08-09

4. Prediction of breast cancer and axillary positive-node response to neoadjuvant chemotherapy based on multi-parametric magnetic resonance imaging radiomics models;The Breast;2024-08

5. Axillary Management Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer;Clinical Breast Cancer;2024-08